FirstMark Capital Co-Founder and Managing Director Amish Jani. FirstMark led the $18 Million Series A for Ezra. Photo by Noam Galai/Getty Images for TechCrunch, under Creative Commons license

Ezra, a New York-based cancer screening and medical imaging startup, has announced it’s raised $18 million in Series A funding led by venture capital firm FirstMark Capital, with participation from a host of both new and existing investors including the likes of Founders Future, Seedcamp, and entrepreneurs Jeff Raider (Harry’s), Dave Gilboa (Warby Parker), Vlad Tenev (Robinhood), and Taavet Hinrikus (TransferWise). Ezra says it’ll use the funding to expand its medical imaging services, which are primarily targeted at detecting cancer.

Ezra is helping to improve early cancer detection with a proprietary full-body MRI scan that typically takes under an hour and screens for cancer in up to 12 organs of the body. The company’s goals entail making cancer screening and early detection easier as well as more affordable. Ezra began offering its cancer screening service last year and currently does so in the cities of New York, San Francisco, and Los Angeles. Also, on the heels of a coronavirus pandemic, Ezra is rolling out tests for — already infected — persons who want to understand the potential long-term impact of the coronavirus on their lung health as well as check their antibody status.

Ezra also happens to be developing artificial intelligence solutions that are intended to assist radiologists in their analysis of MRI-based cancer screening tests, the first of which is currently under review by the U.S. Food and Drug Administration.

Ezra says its cancer screening solutions helped 4% of its testers, mainly asymptomatic, to detect cancer in 2019.

Before now, Ezra is known to have raised $4 million in total funding. With this newly announced Series A, however, that amount has apparently boosted to $22 million.